Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Rhodes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Immunology|November 23, 2006
TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domainDavid A Rhodes, John Trowsdale
Trends in Immunology|August 16, 2017
TRIM21 and the Function of Antibodies inside CellsDavid A Rhodes, David A Isenberg
Annual Review of Immunology|January 17, 2016
Regulation of Immunity by ButyrophilinsDavid A Rhodes, Walter Reith, John Trowsdale
Immunology|November 30, 2005
Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence?David A Rhodes, Bernard de Bono, John Trowsdale
The Journal of Bone and Joint Surgery. American Volume|November 1, 2017
The Olecranon Osteotomy-Facilitated Elbow Release (OFER)Scott G Edwards, David A Rhodes, Thomas W Jordan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2007
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein functionLeo C James, Anthony H Keeble, Zahra Khan, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 19, 2011
Intracellular antibody-mediated immunity and the role of TRIM21William A McEwan, Donna L Mallery, David A Rhodes, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradationDavid A Rhodes, Louise H Boyle, Jessica M Boname, et al.
Clinical Orthopaedics and Related Research|October 22, 2009
Discontinuation of warfarin is unnecessary in total knee arthroplastyDavid A Rhodes, Erik P Severson, Jeffrey T Hodrick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2010
BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activationIsobel A Smith, Brittany R Knezevic, Johannes U Ammann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Immunology|November 23, 2006
TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domainDavid A Rhodes, John Trowsdale
Trends in Immunology|August 16, 2017
TRIM21 and the Function of Antibodies inside CellsDavid A Rhodes, David A Isenberg
Annual Review of Immunology|January 17, 2016
Regulation of Immunity by ButyrophilinsDavid A Rhodes, Walter Reith, John Trowsdale
Immunology|November 30, 2005
Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence?David A Rhodes, Bernard de Bono, John Trowsdale
The Journal of Bone and Joint Surgery. American Volume|November 1, 2017
The Olecranon Osteotomy-Facilitated Elbow Release (OFER)Scott G Edwards, David A Rhodes, Thomas W Jordan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2007
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein functionLeo C James, Anthony H Keeble, Zahra Khan, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 19, 2011
Intracellular antibody-mediated immunity and the role of TRIM21William A McEwan, Donna L Mallery, David A Rhodes, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradationDavid A Rhodes, Louise H Boyle, Jessica M Boname, et al.
Clinical Orthopaedics and Related Research|October 22, 2009
Discontinuation of warfarin is unnecessary in total knee arthroplastyDavid A Rhodes, Erik P Severson, Jeffrey T Hodrick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2010
BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activationIsobel A Smith, Brittany R Knezevic, Johannes U Ammann, et al.
Pageof 2